About

About Medicilon Inc. About Medicilon Medicilon is a global integrated pharmaceutical R&D service contract research organization (CRO), providing a full range of one-stop preclinical R&D services, in compliance with Chinese and international regulatory filing standards, to pharmaceutical companies and research institutions world-wide. Our comprehensive suite of expert services covers the entire process of preclinical new drug research, including drug discovery, pharmacology and toxicology preclinical research. ❖20 Years of Excellence ❖480 IND Approved by FDA, NMPA, EMA, and TGA ❖2000+ Active Clients Worldwide ❖2600+ Scientists & Research Staff ❖85,000+ m2 Lab Space At Medicilon, we are dedicated to support our clients develop their research and discovery programs from initial concept through the IND filing phase. Our services span across medicinal chemistry, biology, API, CMC, formulation, and preclinical studies. We provide flexible business models, including stand-alone Fee for Services (FFS) and fully integrated FTE services. In addition, our facilities are GLP/GMP compliant, US-FDA, China NMPA and AAALAC accredited. All study reports can be presented in SEND format, supporting dual filing of IND applications in the US, EU, and China. For enquiries, please visit our website www.medicilon.com or email marketing@medicilon.com. Medicilon offers fully integrated pharmaceutical services for global scientific community, focusing on providing exceptional client-centered experience and advancing your candidates through the drug discovery process.Our integrated services across biology, chemistry and preclinical services are designed to help clients developing their R&D programs from initial idea stage to IND filing phase. Medicilon is a global integrated pharmaceutical R&D service contract research organization (CRO), providing a full range of one-stop preclinical R&D services, in compliance with Chinese and international regulatory filing standards, to pharmaceutical companies and research institutions world-wide. Our comprehensive suite of expert services covers the entire process of preclinical new drug research, including drug discovery, pharmacology and toxicology preclinical research. ❖20 Years of Excellence ❖480 IND Approved by FDA, NMPA, EMA, and TGA ❖2000+ Active Clients Worldwide ❖2600+ Scientists & Research Staff ❖85,000+ m2 Lab Space At Medicilon, we are dedicated to support our clients develop their research and discovery programs from initial concept through the IND filing phase. Our services span across medicinal chemistry, biology, API, CMC, formulation, and preclinical studies. We provide flexible business models, including stand-alone Fee for Services (FFS) and fully integrated FTE services. In addition, our facilities are GLP/GMP compliant, US-FDA, China NMPA and AAALAC accredited. All study reports can be presented in SEND format, supporting dual filing of IND applications in the US, EU, and China. For enquiries, please visit our website www.medicilon.com or email marketing@medicilon.com. Medicilon is a global integrated pharmaceutical R&D service contract research organization (CRO), providing a full range of one-stop preclinical R&D services, in compliance with Chinese and international regulatory filing standards, to pharmaceutical companies and research institutions world-wide. Our comprehensive suite of expert services covers the entire process of preclinical new drug research, including drug discovery, pharmacology and toxicology preclinical research. ❖20 Years of Excellence ❖480 IND Approved by FDA, NMPA, EMA, and TGA ❖2000+ Active Clients Worldwide ❖2600+ Scientists & Research Staff ❖85,000+ m2 Lab Space At Medicilon, we are dedicated to support our clients develop their research and discovery programs from initial concept through the IND filing phase. Our services span across medicinal chemistry, biology, API, CMC, formulation, and preclinical studies. We provide flexible business models, including stand-alone Fee for Services (FFS) and fully integrated FTE services. In addition, our facilities are GLP/GMP compliant, US-FDA, China NMPA and AAALAC accredited. All study reports can be presented in SEND format, supporting dual filing of IND applications in the US, EU, and China. For enquiries, please visit our website www.medicilon.com or email marketing@medicilon.com.